Top Stories

Overactive Bladder Treatment Market 2018 Global Industry Size Analyzed by Business Opportunity, Development, Growth Factors, Applications Analysis and Future Prospects 2023 | 360 Market Updates

Overactive Bladder Treatment

Overactive Bladder Treatment Market (2018 – 2023) report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The Overactive Bladder Treatment market report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.

Overactive Bladder Treatment Market report is anticipated to register a CAGR of 2.9% over a five years forecast period (2018 – 2023).”

Get a Sample PDF of Report @ https://www.360marketupdates.com/enquiry/request-sample/12887895

List of Major Key players operating in the Global Overactive Bladder Treatment Market are –

  • Allergan PLC.
  • Astellas Pharma Inc.
  • Cogentix Medical Inc.
  • Endo International PLC
  • Hisamitsu Pharmaceutical Co. Inc.
  • Johnson & Johnson
  • Medtronic PLC
  • Pfizer Inc.
  • Sanofi
  • and Teva Pharmaceutical Industries Limited

The global overactive bladder treatment market is expected to register a CAGR of about 2.9% over the forecast period, 2018-2023. The overactive bladder treatments includes various therapies like, anticholinergics, mirabegron, etc., that are used to treat the sudden, involuntary contraction of the muscle in the urinary bladder wall leading to urinary urgency, frequency, nocturia, and urge-incontinence.

Aging Population and Rising Incidence of Diseases Characterized By OAB

In 2017, there were approximately 950 million people who were 60 years old or above, comprising 13% of the global population, and is growing by about 3% every year. Incontinence generally increases with aging. As per a global population-based survey, the estimated prevalence of overactive bladder (OAB) in Europe and Canada was found to be 12.8% in women and 10.8% in men. OAB has a major negative impact on quality of life and health of the aged population. With the increasing burden of OAB, along with other urinary diseases, the growth of the overactive bladder treatment market is likely to be high. Other factors, such as the development of innovative intravesical therapies and aggressive marketing by pharmaceuticals companies, are also expected to expand the market.

Undesired Systemic Effects of the Current OAB Treatments

Anticholinergic have been linked to the burden to dementia or Alzheimer’s disease in a few recent studies. In a recent publication by SL Gray, 3434 participants were studied and a 10-year cumulative dose response relationship was found to exist between the usage of anticholinergic drugs and the risk of developing dementia. Anticholinergic has also been linked with increased mortality and cardiovascular diseases. These factors may deter healthcare providers from using these treatment options. Also the increasing awareness about these side effects among users will lead to the slowdown of the growth of this market.

North America to Dominate the Market

North America has dominated the overactive bladder treatment market, which can be primarily attributed to its well-established healthcare industry which has favorable reimbursement of overactive bladder treatment, growing prevalence of the disease with rising age, and the presence of major players. Asia-Pacific region is expected to witness the highest CAGR during the forecast period, due to rising prevalence of bladder overactivity, increasing geriatric population, rising healthcare expenditure, and growing awareness of overactive bladder.

Major Players: ALLERGAN PLC., ASTELLAS PHARMA INC., COGENTIX MEDICAL INC., ENDO INTERNATIONAL PLC, HISAMITSU PHARMACEUTICAL CO. INC., JOHNSON & JOHNSON, MEDTRONIC PLC, PFIZER INC., SANOFI, AND TEVA PHARMACEUTICAL INDUSTRIES LIMITED, amongst others.

Share your query before purchasing this report @ https://www.360marketupdates.com/enquiry/pre-order-enquiry/12887895

Scope of the Report:

The report analyses Overactive Bladder Treatment market, which includes –

  • Analysis of the growth of Overactive Bladder Treatment market in global and regional level including Asia-Pacific, Americas, and EMEA.
  • The report provides Overactive Bladder Treatment market analysis for key countries including the US, Canada, Chile, China, India, Japan, the UK, Germany, France, and Italy.
  • The report offers country level Overactive Bladder Treatment market volume and value by end-user segment for the period 2012-2023.
  • Qualitative analysis of key market drivers and restraints, and analysis of their impacts on Overactive Bladder Treatment market are discussed.
  • The report provides competitive landscape at country level for the year 2018. It also covers key policies and initiatives, key deals, and key upcoming projects.

Highlighted points of Overactive Bladder Treatment Market Report:

  • Varying dynamics of the Overactive Bladder Treatment industry.
  • Prospective changes in sales volumes and worldwide share growth in upcoming years (2018-2023).
  • Overactive Bladder Treatment market report recognizes the key drivers of growth and challenges of the key industry players.
  • Competitors profiles along with product description, overview, and business data.
  • A complete analysis of market risks, opportunities, limitations, and growth of the market.
  • Market driving and restraining factors.
  • Delivers information on the historical and current market size and the future potential of the market.
  • Overactive Bladder Treatment market report provides a comprehensive analysis of the market with respect to market dynamics, competitive analysis, and upcoming trends of the market.

Purchase this report (Price 4250 USD for a single-user license) @ https://www.360marketupdates.com/purchase/12887895

Reasons to Purchase Overactive Bladder Treatment Market Report:

  • The report analyses how stringent emission control norms will drive the global Overactive Bladder Treatment market.
  • Analyzing various perspectives of the market with the help of Porter’s five forces analysis.
  • Study on the product type that is expected to dominate the market.
  • Study on the regions that are expected to witness the fastest growth during the forecast period.
  • Identify the latest developments, market shares and strategies employed by the major Overactive Bladder Treatment market players.
  • 3 months’ analyst support along with the Market Estimate sheet (in excel).

In this study, the years considered to estimate the market size of Overactive Bladder Treatment:

History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2023

Look into Table of Content of Overactive Bladder Treatment Market Report @ https://www.360marketupdates.com/TOC/12887895#TOC

Contact Info: –

360 Market Updates

Mr. Ajay More

USA: +1 424 253 0807

UK: +44 203 239 8187

[email protected]

Tags:- “Overactive Bladder Treatment, Overactive Bladder Treatment Market, Overactive Bladder Treatment Europe Market, Overactive Bladder Treatment APAC Market, Overactive Bladder Treatment Market By Application, Overactive Bladder Treatment Market By Rising Trends, Overactive Bladder Treatment Market Development, Overactive Bladder Treatment Market Forecast, Overactive Bladder Treatment Market Future, Overactive Bladder Treatment Market Growth, Overactive Bladder Treatment Market In Key Countries, Overactive Bladder Treatment Market Latest Report, Overactive Bladder Treatment Market Swot Analysis, Overactive Bladder Treatment Market Top Manufacturers, Overactive Bladder Treatment Sales Market, Overactive Bladder Treatment United States Market, Overactive Bladder Treatment Market share, Overactive Bladder Treatment Market Size, Overactive Bladder Treatment market Trends, Overactive Bladder Treatment Market 2018, Overactive Bladder Treatment market 2019”